Clinical guidance news Archives | Dispensing Doctors' Association

February 13th 2025

16 conditions and indications highlighted for POM-P switching

Some 16 conditions and indications suitable for reclassification to pharmacy sale have been announced by the DHSC. The list aims to encourage more reclassification applications, but it does not guarantee approval by the MHRA. All applica

February 11th 2025

Greater use of biosimilars proposed in draft secondary care contract

A draft secondary care contract for 2025-26 proposes greater use of biosimilar medicines and reduced referrals to GPs. NHS England » Draft NHS Standard Contract 2025/26: A consultation – proposed changes to the NHS Standard Contract for

December 12th 2024

GnRH ban extended indefinitely

Regulations restricting the prescribing and supply of puberty-suppressing hormones will be made indefinite. There were due to expire at the end of December. The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sale

Hot topics

DM Zone news HR Zone news Clinical guidance news Political News Scotland Wales Rurality Supply Shortages COVID19

December 9th 2024

15 items earmarked for deprescribing on Scottish NHS

Scotland has published deprescribing guidance for medicines of low and limited clinical value. The guidance lists 15 items of low value, where prescribers should either deprescribe or initiate alternative products. The items include: minocycline for

November 8th 2024

GnRH restrictions extended again

The Government has made The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024, which has the effect of extending the ban, which was due to expire. The ban has now been extended until 31

September 9th 2024

New safety advice for valproate use in men

Men taking valproate are being advised to use effective contraception during valproate treatment and for at least three months after stopping valproate. New MHRA safety advice follows research that reports a possible association between valproate us

August 27th 2024

Temporary ban on GnRH analogues extended

The government has renewed a temporary ban on the sale and supply of gonadotrophin-releasing hormone analogues (c) The continuation of the ban until 26 November 2024 applies to the sale or supply of these drugs, prescribed by pr